You are here

Clinical Trials: Liver Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, September 12, 2018 - 12:00
Condition:   Primary Biliary Cirrhosis
Intervention:   Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor:   Xijing Hospital of Digestive Diseases
Recruiting
Posted: Wednesday, September 12, 2018 - 12:00
Condition:   Acute-On-Chronic Liver Failure
Intervention:   Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor:   Xijing Hospital of Digestive Diseases
Recruiting
Posted: Friday, May 18, 2018 - 12:00
Condition:   Decompensated Liver Cirrhosis
Intervention:   Biological: UC-MSC
Sponsors:   Shandong Qilu Stem Cells Engineering Co., Ltd.;   Shanghai Public Health Clinical Center;   First Affiliated Hospital of Fujian Medical University;   Yantai Hospital for Infectious Diseases;   The Second Affiliated Hospital of Chongqing Medical University;   Jinan Hospital for Infectious Diseases
Not yet recruiting
Posted: Friday, March 9, 2018 - 12:00
Condition:   Liver Cirrhosis
Intervention:   Biological: MSC
Sponsor:   Nanjing Medical University
Not yet recruiting
Posted: Thursday, August 3, 2017 - 12:00
Condition:   Decompensated Liver Cirrhosis
Intervention:   Biological: Mesenchymal stem cell
Sponsor:   Rohto Pharmaceutical Co., Ltd.
Recruiting - verified August 2017
Posted: Friday, June 30, 2017 - 12:00
Condition:   Liver Cirrhosis
Interventions:   Procedure: mesenchymal stem cell transplantation via peripheral vein;   Other: mesenchymal stem cell
Sponsor:   Xijing Hospital of Digestive Diseases
Recruiting - verified July 2017
Posted: Monday, March 6, 2017 - 12:00
Condition:   End Stage Liver Disease
Interventions:   Drug: Neupogen;   Procedure: CD133 Cells Transplantation
Sponsors:   National University Hospital, Singapore;   Singapore General Hospital;   Tan Tock Seng Hospital;   Changi General Hospital Singapore
Recruiting - verified February 2017
Posted: Wednesday, November 9, 2016 - 12:00
Condition:   Alcoholic Hepatitis
Interventions:   Drug: standard medical therapy;   Drug: G-CSF;   Drug: n-Acetylcysteine
Sponsor:   Postgraduate Institute of Medical Education and Research
Recruiting - verified November 2016
Posted: Monday, September 19, 2016 - 12:00
Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: Fulvestrant
Sponsor:   University of Pennsylvania
Recruiting - verified March 2017
Posted: Friday, May 27, 2016 - 12:00
Condition:   Liver Failure
Intervention:   Drug: umbilical cord blood mesenchymal stem cells
Sponsor:   Sun Yat-sen University
Not yet recruiting - verified June 2016

Pages